• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性川崎病期间血清中p60可溶性肿瘤坏死因子受体水平

Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease.

作者信息

Furukawa S, Matsubara T, Umezawa Y, Okumura K, Yabuta K

机构信息

Department of Pediatrics, Yamaguchi University School of Medicine, Japan.

出版信息

J Pediatr. 1994 May;124(5 Pt 1):721-5. doi: 10.1016/s0022-3476(05)81361-7.

DOI:10.1016/s0022-3476(05)81361-7
PMID:8176558
Abstract

To evaluate the role of tumor necrosis factor alpha (TNF-alpha) during acute Kawasaki disease, we measured p60 soluble tumor necrosis factor receptor (sT-NF-R) shedding into the circulation in 48 patients with acute Kawasaki disease, all of whom received intravenous infusions of gamma-globulin. Of the 48 patients, 5 had coronary artery lesions. Serum concentrations of p60 sTNF-R and TNF-alpha were measured by a sandwich enzyme immunoassay. Patients with Kawasaki disease had increased serum levels of p60 sTNF-R. We found a positive correlation between serum levels of p60 sTNF-R and levels of TNF alpha during acute Kawasaki disease. Moreover, patients with coronary artery lesions had higher levels of sTNF-R than did those without coronary artery lesions. Our findings indicate that p60 sTNF-R levels in serum may be useful for determining the severity of vascular damage during acute Kawasaki disease, and that patients with Kawasaki disease and high sTNF-R levels seem to be susceptible to coronary artery lesions even if they receive therapy with intravenous infusions of gamma-globulin.

摘要

为评估肿瘤坏死因子α(TNF-α)在急性川崎病中的作用,我们检测了48例急性川崎病患者循环中p60可溶性肿瘤坏死因子受体(sTNF-R)的释放情况,所有患者均接受了静脉注射丙种球蛋白治疗。48例患者中,5例有冠状动脉病变。采用夹心酶免疫测定法检测血清中p60 sTNF-R和TNF-α的浓度。川崎病患者血清p60 sTNF-R水平升高。我们发现急性川崎病期间血清p60 sTNF-R水平与TNF-α水平呈正相关。此外,有冠状动脉病变的患者sTNF-R水平高于无冠状动脉病变的患者。我们的研究结果表明,血清中p60 sTNF-R水平可能有助于确定急性川崎病期间血管损伤的严重程度,并且即使接受静脉注射丙种球蛋白治疗,川崎病患者且sTNF-R水平高者似乎易患冠状动脉病变。

相似文献

1
Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease.急性川崎病期间血清中p60可溶性肿瘤坏死因子受体水平
J Pediatr. 1994 May;124(5 Pt 1):721-5. doi: 10.1016/s0022-3476(05)81361-7.
2
[Soluble intercellular adhesion molecule-I levels in sera of patients with Kawasaki disease].[川崎病患者血清中可溶性细胞间黏附分子-1水平]
Arerugi. 1992 Oct;41(10):1507-14.
3
Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum.川崎病在血清肿瘤坏死因子-α和白细胞介素6方面与过敏性紫癜及麻疹不同。
Eur J Pediatr. 1992 Jan;151(1):44-7. doi: 10.1007/BF02073890.
4
Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease.川崎病中循环细胞间黏附分子1水平升高。
Arthritis Rheum. 1992 Jun;35(6):672-7. doi: 10.1002/art.1780350611.
5
Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions.川崎病合并冠状动脉病变时血清肿瘤坏死因子、白细胞介素2受体及γ干扰素水平
Clin Immunol Immunopathol. 1990 Jul;56(1):29-36. doi: 10.1016/0090-1229(90)90166-n.
6
Cerebrospinal fluid levels of soluble tumour necrosis factor receptor in acute encephalitis.
J Neurol. 1996 Jun;243(6):457-60. doi: 10.1007/BF00900499.
7
Cerebrospinal fluid concentrations of soluble tumor necrosis factor receptor in bacterial and aseptic meningitis.
Neurology. 1996 Mar;46(3):837-8. doi: 10.1212/wnl.46.3.837.
8
[Interleukin 6 activities and tumor necrosis factor-alpha levels in serum of patients with Kawasaki disease].[川崎病患者血清中白细胞介素6活性及肿瘤坏死因子-α水平]
Arerugi. 1991 Feb;40(2):147-54.
9
The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome.可溶性60 kDa肿瘤坏死因子受体:复发缓解型多发性硬化症患者与对照组之间未发现差异;水平升高与吉兰-巴雷综合征的恢复相关。
J Neurol. 1998 Dec;245(12):803-8. doi: 10.1007/s004150050290.
10
[Serum gamma interferon levels in relation to tumor necrosis factor and interleukin 2 receptor in patients with Kawasaki disease involving coronary-artery lesions].[川崎病合并冠状动脉病变患者血清γ干扰素水平与肿瘤坏死因子及白细胞介素2受体的关系]
Arerugi. 1990 Feb;39(2 Pt 1):118-23.

引用本文的文献

1
Protective Effect of > Gene Polymorphism on Coronary Outcome of Kawasaki Disease in Southern Chinese Population.>基因多态性对中国南方人群川崎病冠状动脉结局的保护作用。
Front Genet. 2021 Aug 17;12:691282. doi: 10.3389/fgene.2021.691282. eCollection 2021.
2
Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients.免疫球蛋白静脉注射和英夫利昔单抗难治性川崎病患者生物标志物血清水平分析。
Clin Rheumatol. 2018 Jul;37(7):1937-1943. doi: 10.1007/s10067-017-3952-7. Epub 2018 Jan 4.
3
Treatment Options for Resistant Kawasaki Disease.
难治性川崎病的治疗选择
Paediatr Drugs. 2018 Feb;20(1):59-80. doi: 10.1007/s40272-017-0269-6.
4
Pediatric Kawasaki Disease and Adult Human Immunodeficiency Virus Kawasaki-Like Syndrome Are Likely the Same Malady.小儿川崎病和成人人类免疫缺陷病毒相关性川崎样综合征可能是同一种疾病。
Open Forum Infect Dis. 2016 Sep 29;3(3):ofw160. doi: 10.1093/ofid/ofw160. eCollection 2016 Sep.
5
Pharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in kawasaki disease.己酮可可碱儿科口服制剂在川崎病中的药代动力学及耐受性评估
Curr Ther Res Clin Exp. 2003 Feb;64(2):96-115. doi: 10.1016/S0011-393X(03)00018-3.
6
Etanercept suppresses arteritis in a murine model of kawasaki disease: a comparative study involving different biological agents.依那西普在川崎病小鼠模型中抑制动脉炎:一项涉及不同生物制剂的比较研究。
Int J Vasc Med. 2013;2013:543141. doi: 10.1155/2013/543141. Epub 2013 Mar 31.
7
Superantigen involvement and susceptibility factors in Kawasaki disease: profiles of TCR Vβ2+ T cells and HLA-DRB1, TNF-α and ITPKC genes among Filipino patients.川崎病中的超抗原参与及易感因素:菲律宾患者中TCR Vβ2 + T细胞和HLA - DRB1、TNF-α及ITPKC基因概况
Int J Mol Epidemiol Genet. 2013;4(1):70-6. Epub 2013 Mar 18.
8
Prospective open-label trial of etanercept as adjunctive therapy for kawasaki disease.前瞻性开放标签试验:依那西普作为川崎病辅助治疗的应用。
J Pediatr. 2010 Dec;157(6):960-966.e1. doi: 10.1016/j.jpeds.2010.06.014. Epub 2010 Jul 27.
9
Serum resistin concentrations in children with Kawasaki disease.川崎病患儿血清抵抗素浓度。
Inflamm Res. 2010 Nov;59(11):915-20. doi: 10.1007/s00011-010-0202-8. Epub 2010 Apr 27.
10
The CCR5 (-2135C/T) polymorphism may be associated with the development of Kawasaki disease in Korean children.CCR5基因(-2135C/T)多态性可能与韩国儿童川崎病的发生有关。
J Clin Immunol. 2009 Jan;29(1):22-8. doi: 10.1007/s10875-008-9218-z. Epub 2008 Jul 15.